91制片厂

List of Tables:

Table 3-1: Macroeconomic Overview (2017-2021)
Table 3-2: Demographic Characteristics (2017-2021)
Table 4-1: Top 10 Countries for Exports of Pharmaceuticals (FY 2021)
Table 8-1: Leading Approved Biosimilars India
Table 9-1: Key Acquisitions in Pharmaceutical Industry
Table 9-2: Aurobindo Pharma - Key Financials (Billion INR), FY 2019 to FY 2021
Table 9-3: Cipla Limited - Key Financials (Billion INR), FY 2019 to FY 2021
Table 9-4: Dr. Reddys Labs - Key Financials (Billion INR), FY 2019 to FY 2021
Table 9-5: Sun Pharma - Key Financials (Billion INR), FY 2019 to FY 2021
Table 9-6: Lupin - Key Financials (Billion INR), FY 2019 to FY 2021 List of Figures:

Figure 3-1: FDI Equity Inflow (Billion US$), FY 2017 to FY 2022
Figure 3-2: FDI Equity Inflow in Pharmaceuticals (Billion US$), FY 2020 to FY 2022
Figure 4-1: Pharmaceutical Industry (Billion US$), FY 2016 to FY 2021
Figure 4-2: Breakup of Pharmaceutical Industry (%), FY 2021
Figure 4-3: Domestic Pharmaceutical Market (Billion US$), FY 2016 to FY 2021
Figure 4-4: Export of Pharmaceuticals (Billion US$), FY 2016 to FY 2021
Figure 4-5: Pharmaceutical Exports by Segment (%), FY 2021
Figure 4-6: Domestic Pharmaceutical Market (Billion US$), FY 2022 to FY 2026
Figure 4-7: Worldwide Total Prescription Drug Revenue at Risk from Patent Expiration (Billion US$), 2022-2026
Figure 5-1: Domestic Drug Formulations Market by Category (%), FY 2026
Figure 5-2: Bulk Drugs Export (Billion US$), FY 2016 to FY 2021
Figure 5-3: Domestic Drug Formulations Market (Billion US$), FY 2016 to FY 2021
Figure 5-4: Drug Formulations Export (Billion US$), FY 2016 to FY 2021
Figure 5-5: Domestic Pharmaceutical Market by Therapeutic Category (%), FY 2021
Figure 5-6: Anti-Infectives Market (Million US$), FY 2021 & FY 2026
Figure 5-7: Gastrointestinal Drugs Market (Million US$), FY 2021 & FY 2026
Figure 5-8: Vitamins/Minerals/Nutrients Market (Million US$), FY 2021 & FY 2026
Figure 5-9: Pain/Analgesics Market (Million US$), FY 2021 & FY 2026
Figure 5-10: Dermatology Market (Million US$), FY 2021 & FY 2026
Figure 5-11: Gynecology Market (Million US$), FY 2021 & FY 2026
Figure 5-12: Number of Asthma Patients (Million), 2020 & 2030
Figure 5-13: Respiratory Drugs Market (Million US$), FY 2021 & FY 2026
Figure 5-14: Cardiac Drugs Market (Million US$), FY 2021 & FY 2026
Figure 5-15: Neuro/CNS Drugs Market (Million US$), FY 2021 & FY 2026
Figure 5-16: Number of adults (20鈥�79 years) with Diabetes (Million), 2021 & 2045
Figure 5-17: Anti-Diabetic Market (Million US$), FY 2021 & FY 2026
Figure 6-1: Pharmaceutical Distribution Channel
Figure 8-1: Contract Manufacture and Research Services Market (Billion US$), 2018 to 2026
Figure 8-2: Number of Registered Clinical Trials (2011-2017)
Figure 8-3: Number of Approved Clinical Trials (2013 & 2021)
Figure 8-4: Clinical Trials by Phase (%)
Figure 8-5: Clinical Trials by Condition (%)
Figure 8-6: Clinical Trials Market (Billion US$), 2021-2026
Figure 8-7: Pharma Packaging Market (Million US$), 2021-2026
Figure 9-1: Share of Leading Companies in Pharmaceutical Market (FY 2021)